Abstract
Nanobiotechnology is an important field with many new applications. This opportunity has been greatly embraced by the medical research community in the continuous search of novel opportunities for improving disease diagnosis, drug design and delivery. Understanding the mechanisms of disease for the design of new drugs is not enough, and unfortunately, infectious diseases continue to be a major health burden worldwide. Since ancient times, metals and especially silver were known for their antibacterial effects, but these days available methodologies allow the further exploitation of metal in the form of nanoscale materials. Metal nanoparticles are attracting much interest because of their potent antibacterial activity, but many studies have also shown a meaningful activity of metal nanoparticles against viruses, fungi and parasites. This chapter aims to summarize emerging efforts for the application of metallic nanoparticles in the never-ending battle against parasitic diseases. We have focused on four of the major parasitic diseases that afflict millions of people worldwide, specifically malaria, leishmaniasis, trypanosomiasis and schistosomiasis. The failure to respond to the increasing demand for effective antiparasitic drugs made imperative to explore new avenues; therefore, metal and metal oxide nanoparticles seem to represent an excellent therapeutic alternative.
Abbreviations
- Ag:
-
Silver
- Ag2O:
-
Silver oxide
- AgNPs:
-
Silver NPs
- AgNPs:
-
Silver NPs
- AK:
-
Arginine kinase
- AmB:
-
Amphotericin B
- Au:
-
Gold
- AuNPs:
-
Gold NPs
- CaO:
-
Calcium oxide
- CL:
-
Cutaneous leishmaniasis
- CNS:
-
Central nervous system
- CQ:
-
Chloroquine
- CQ-r:
-
CQ-resistant
- CQ-s:
-
CQ-sensitive
- CuO:
-
Copper oxide
- DA:
-
Dopamine
- FDA:
-
Food and drugs administration
- FRET:
-
Fluorescence energy transfer
- GSH:
-
Glutathione S-transferase
- HBV:
-
Hepatitis B virus
- HIV-1:
-
Human immunodeficiency virus type-1
- HPIV-3:
-
Human parainfluenza virus type 3
- HSV-1:
-
Herpes simplex virus type 1
- HSV-2:
-
Herpes simplex virus type 2
- MA:
-
Meglumine antimoniate
- MDA:
-
Malondialdehyde
- MgO:
-
Magnesium oxide
- MgONPs:
-
Magnesium oxide NPs
- ML:
-
Muco-cutaneous
- MPV:
-
Monkeypox virus
- MRSA:
-
Methicillin–resistant Staphylococcus aureus
- MRSE:
-
Methicillin–resistant Staphylococcus epidermidis
- MTT:
-
Tetrazolium salt colorimetric assay
- NE:
-
Norepinephrine
- NO:
-
Nitric oxide
- NPs:
-
Nanoparticles
- PdNPs:
-
Palladium NPs
- PfCRT:
-
P. falciparum chloroquine resistance transport
- PfThzK:
-
5-(2-hydroxyethyl)-4-methylthiazolekinase
- PZQ:
-
Praziquantel
- ROS:
-
Reactive oxygen species
- SeNPs:
-
Selenium nanoparticles
- SiO2 :
-
Silicon dioxide
- TbAK:
-
Trypanosoma brucei AK
- TCRV:
-
Tacaribe virus
- TiO2 :
-
Titanium dioxide
- TiO2Ag-NPs:
-
Silver-doped titanium dioxide nanoparticles
References
Abamor ES, Allahverdiyev AM (2016) A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles—Nigella sativa oil combinations. Exp Parasitol 166:150–163
Adeyemi OS, Whiteley CG (2013) Interaction of nanoparticles with arginine kinase from Trypanosoma brucei: Kinetic and mechanistic evaluation. Int J Biol Macromol 62:450–456
Adeyemi OS, Whiteley CG (2014) Interaction of metal nanoparticles with recombinant arginine kinase from Trypanosoma brucei: Thermodynamic and spectrofluorimetric evaluation. Biochem Biophys Acta 1840:701–706
Ahmad A, Wei Y, Syed F, Khan S, Khan GM, Tahir K, Khan AU, Raza M, Khan FU, Yuan O (2016) Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: a novel green approach. J Photochem Photobiol B 161:17–24
Allahverdiyev AM, Abamor ES, Bagirova M, Ustundag CB, Kaya C, Kaya F, Rafailovich M (2011) Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomed 6:2705–2714
Allahverdiyev AM, Abamor ES, Bagirova M, Baydar SY, Ates SC, Kaya F, Kaya C, Rafailovich M (2013) Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro. Exp Parasitol 135:55–63
Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, Rotello VM, Prakash YS, Mukherjee P (2010) Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett 10:2543–2548
Asilian A, Davami M (2006) Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 31:634–637
Bafghi AF, Daghighi M, Daliri K, Jebali A (2015) Magnesium oxide nanoparticles coated with glucose can silence important genes of Leishmania major at sub-toxic concentrations. Colloids Surf B 136:300–304
Bahadar H, Maqbool F, Niaz K, Abdollahi M (2016) Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J 20:1–11
Baiocco P, Ilari A, Ceci P, Orsini S, Gramiccia M, Di Muccio T, Colotti G (2010) Inhibitory effect of silver nanoparticles on Trypanothione reductase activity and Leishmania infantum proliferation. ACS Med Chem Lett 2:230–233
Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R (2009) Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 20:1497–1502
Baram-Pinto D, Shukla S, Gedanken A, Sarid R (2010) Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small 6:1044–1050
Beheshti N, Soflaei S, Shakibaie M, Yazdi MH, Ghaffarifar F, Dalimi A, Shahverdi AR (2013) Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies. J Trace Elem Med Biol 27:203–207
Benelli G (2016) Plant-mediated biosynthesis of nanoparticles as an emerging tool against mosquitoes of medical and veterinary importance: a review. Parasitol Res 115:23–34
Bowman MC, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander C (2008) Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130:6896–6897
Butkus MA, Labare MP, Starke JA, Moon K, Talbot M (2004) Use of aqueous silver to enhance inactivation of coliphage MS-2 by UV disinfection. Appl Environ Microbiol 70:2848–2853
Chen N, Zheng Y, Yin J, Li X, Zheng C (2013) Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro. J Virol Methods 193:470–477
Cheng Y, Chen X, Song W, Kong Z, Li P, Liu Y (2013) Contribution of silver ions to the inhibition of infectivity of Schistosoma japonicum cercariae caused by silver nanoparticles. Parasitology 140:617–625
Daily JP (2017) Malaria 2017: update on the clinical literature and management. Current infectious disease reports
Das S, Roy P, Mondal S, Bera T, Mukherjee A (2013) One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis. Colloids Surf B 107:27–34
den Boer M, Argaw D, Jannin J, Alvar J (2011) Leishmaniasis impact and treatment access. Clin Microbiol Infect 17:1471–1477
DeRussy BM, Aylward MA, Fan Z, Ray PC, Tandon R (2014) Inhibition of cytomegalovirus infection and photothermolysis of infected cells using bioconjugated gold nanoparticles. Sci Rep 4:5550
Dinesh D, Murugan K, Madhiyazhagan P, Panneerselvam C, Kumar PM, Nicoletti M, Jiang W, Benelli G, Chandramohan B, Suresh U (2015) Mosquitocidal and antibacterial activity of green-synthesized silver nanoparticles from Aloe vera extracts: towards an effective tool against the malaria vector Anopheles stephensi? Parasitol Res 114:1519–1529
Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K (2014) Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl 44:278–284
Dizaj SM, Mennati A, Jafari S, Khezri K, Adibkia K (2015) Antimicrobial activity of carbon-based nanoparticles. Adv Pharm Bull 5:19–23
Dkhil MA, Bauomy AA, Diab MS, Wahab R, Delic D, Al-Quraishy S (2015a) Impact of gold nanoparticles on brain of mice infected with Schistosoma mansoni. Parasitol Res 114:3711–3719
Dkhil MA, Bauomy AA, Diab MS, Al-Quraishy S (2015b) Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis. Int J Nanomed 10:7467–7475
Dkhil MA, Bauomy AA, Diab MS, Al-Quraishy S (2016a) Protective role of selenium nanoparticles against Schistosoma mansoni induced hepatic injury in mice. Biomed Res 27:214–219
Dkhil MA, Khalil MF, Bauomy AA, Diab MS, Al-Quraishy S (2016b) Efficacy of gold nanoparticles against nephrotoxicity Induced by Schistosoma mansoni infection in mice. Biomed Environ Sci 29:773–781
Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659–667
dos Santos CA, Seckler MM, Ingle AP, Gupta I, Galdiero S, Galdiero M, Gade A, Rai M (2014) Silver nanoparticles: therapeutical uses, toxicity, and safety issues. J Pharm Sci 103:1931–1944
Durán M, Faljoni-Alario A, Durán N (2010) Chromobacterium violaceum and its important metabolites–review. Folia Microbiol 55:535–547
Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ (2005) Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 3:6
Esteban-Tejeda L, Malpartida F, Esteban-Cubillo A, Pecharromán C, Moya JS (2009) The antibacterial and antifungal activity of a soda-lime glass containing silver nanoparticles. Nanotechnology 20:085103
Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M (2015) Silver nanoparticles as potential antibacterial agents. Molecules 20:8856–8874
Freitas-Junior LH, Chatelain E, Kim HA, Siqueira-Neto JL (2012) Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it? Int J Parasitol Drugs Drug Resist 2:11–19
Gaikwad S, Ingle A, Gade A, Rai M, Falanga A, Incoronato N, Russo L, Galdiero S, Galdiero M (2013) Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomed 8:4303–4314
Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M (2011) Silver nanoparticles as potential antiviral agents. Molecules 16:8894–8918
Gardella F, Assi S, Simon F, Bogreau H, Eggelte T, Ba F, Foumane V, Henry MC, Kientega PT, Basco L, Trape JF, Lalou R, Martelloni M, Desbordes M, Baragatti M, Briolant S, Almeras L, Pradines B, Fusai T, Rogier C (2008) Antimalarial drug use in general populations of tropical Africa. Malaria J 7:124
Ge L, Li Q, Wang M, Ouyang J, Li X, Xing MM (2014) Nanosilver particles in medical applications: synthesis, performance, and toxicity. Int J Nanomed 9:2399–2407
Genes C, Baquero E, Echeverri F, Maya JD, Triana O (2011) Mitochondrial dysfunction in Trypanosoma cruzi: the role of Serratia marcescens prodigiosin in the alternative treatment of Chagas disease. Parasites Vectors 4:66
Ghule K, Ghule AV, Chen BJ, Ling YC (2006) Preparation and characterization of ZnO nanoparticles coated paper and its antibacterial activity study. Green Chem 8:1034–1041
Golbamaki N, Rasulev B, Cassano A, Marchese Robinson RL, Benfenati E, Leszczynski J, Cronin MT (2015) Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms. Nanoscale 7:2154–2198
Gopinath V, Velusamy P (2013) Extracellular biosynthesis of silver nanoparticles using Bacillus sp GP-23 and evaluation of their antifungal activity towards Fusarium oxysporum. Spectrochim Acta Part A Mol Biomol Spectrosc 106:170–174
Gutiérrez V, Seabra AB, Reguera RM, Khandare J, Calderón M (2016) New approaches from nanomedicine for treating leishmaniasis. Chem Soc Rev 45:152–168
Hadrup N, Sharma AK, Poulsen M, Nielsen E (2015) Toxicological risk assessment of elemental gold following oral exposure to sheets and nanoparticles—a review. Regul Toxicol Pharmacol 72:216–221
Hannan A, Saleem S, Chaudhary S, Barkaat M, Arshad MU (2008) Antibacterial activity of Nigella sativa against clinical isolates of methicillin resistant Staphylococcus aureus. J Ayub Med Coll Abbottabad 20:72–74
Hu RL, Li SR, Kong FJ, Hou RJ, Guan XL, Guo F (2014) Inhibition effect of silver nanoparticles on herpes simplex virus 2. Genet Mol Res 13:7022–7028
Jaganathan A, Murugan K, Panneerselvam C, Madhiyazhagan P, Dinesh D, Vadivalagan C, Aziz AT, Chandramohan B, Suresh U, Rajaganesh R, Subramaniam J, Nicoletti M, Higuchi A, Alarfaj AA, Munusamy MA, Kumar S, Benelli G (2016) Earthworm-mediated synthesis of silver nanoparticles: a potent tool against hepatocellular carcinoma, Plasmodium falciparum parasites and malaria mosquitoes. Parasitol Int 65:276–284
Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM (2009) Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm 6:1388–1401
Jebali A, Kazemi B (2013) Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis. Toxicol In Vitro 27:1896–1904
Jo DH, Kim JH, Lee TG, Kim JH (2015) Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomedicine 11:1603–1611
Kalangi SK, Dayakar A, Gangappa D, Sathyavathi R, Maurya RS, Narayana Rao D (2016) Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the antileishmanial efficacy of miltefosine. Exp Parasitol 170:184–192
Karthik L, Kumar G, Keswani T, Bhattacharyya A, Reddy BP, Rao KV (2013) Marine actinobacterial mediated gold nanoparticles synthesis and their antimalarial activity. Nanomedicine 9:951–960
Kesarkar RO, Oza G, Pandey S, Dahake R, Mukherjee S, Chowdhary A, Sharon M (2012) Gold nanoparticles: effective as both entry inhibitors and virus neutralizing agents against HIV. J Microbiol Biotechnol Res 2:276
Khan S, Ansari AA, Khan AA, Abdulla M, Al-Obaid O, Ahmad R (2017) In vitro evaluation of cytotoxicity, possible alteration of apoptotic regulatory proteins, and antibacterial activity of synthesized copper oxide nanoparticles. Colloids Surf B 153:320–326
Kim JY, Lee C, Cho M, Yoon J (2008) Enhanced inactivation of E. coli and MS-2 phage by silver ions combined with UV-A and visible light irradiation. Water Res 42:356–362
King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365:1561–1569
Klein TY, Wehling J, Treccani L, Rezwan K (2013) Effective bacterial inactivation and removal of copper by porous ceramics with high surface area. Environ Sci Technol 47:1065–1072
Krishnaraj C, Ramachandran R, Mohan K, Kalaichelvan PT (2012) Optimization for rapid synthesis of silver nanoparticles and its effect on phytopathogenic fungi. Spectrochim Acta Part A Mol Biomol Spectrosc 93:95–99
Kwak SY, Kim SH, Kim SS (2001) Hybrid organic/inorganic reverse osmosis (RO) membrane for bactericidal anti-fouling. Preparation and characterization of TiO2 nanoparticle self-assembled aromatic polyamide thin-film-composite (TFC) membrane. Environ Sci Technol 35:2388–2394
Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C (2010a) Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol 8:1
Lara HH, Ixtepan-Turrent L, Garza-Treviño EN, Rodriguez-Padilla C (2010b) PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J Nanobiotechnol 8:15
Lellouche J, Kahana E, Elias S, Gedanken A, Banin E (2009) Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 30:5969–5978
Lodge R, Descoteaux A (2006) Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Eur J Immunol 36:2735–2744
Lopes SC, Blanco YC, Justo GZ, Nogueira PA, Rodrigues FL, Goelnitz U, Wunderlich G, Facchini G, Brocchi M, Duran N, Costa FT (2009) Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. Antimicrob Agents Chemother 53:2149–2152
Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK, Che CM (2008) Silver nanoparticles inhibit hepatitis B virus replication. Antiviral Ther 13:253–262
Mahmoud MR, El-Abhar HS, Saleh S (2002) The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol 79:1–11
Mahmoudvand H, Shakibaie M, Tavakoli R, Jahanbakhsh S, Sharifi I (2014) In vitro study of leishmanicidal activity of biogenic selenium nanoparticles against iranian isolate of sensitive and glucantime-resistant Leishmania tropica. Iran J Parasitol 9:452–460
Mahmoudvand H, Tavakoli R, Sharififar F, Minaie K, Ezatpour B, Jahanbakhsh S, Sharifi I (2015) Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone. Pharm Biol 53:1052–1057
Mastro AM, Hardy AW, Boasso A, Shearer GM, Eddy CR Jr, Kub FJ (2010) Non-toxic inhibition of HIV-1 replication with silver–copper nanoparticles. Med Chem Res 19:1074–1081
McGwire BS, Satoskar AR (2014) Leishmaniasis: clinical syndromes and treatment. QJM: Int J Med 107:7–14
Mehrbod P, Motamed N, Tabatabaian M, Estyar RS, Amini E, Shahidi M, Kheiri MT (2009) In Vitro antiviral effect of “Nanosilver” on influenza virus. DARU J Pharm Sci 17:88–93
Mehta A, Shaha C (2006) Mechanism of metalloid-induced death in Leishmania spp.: role of iron, reactive oxygen species, Ca2+, and glutathione. Free Radic Biol Med 40:1857–1868
Miranda MR, Canepa GE, Bouvier LA, Pereira CA (2006) Trypanosoma cruzi: oxidative stress induces arginine kinase expression. Exp Parasitol 114:341–344
Mishra A, Kaushik NK, Sardar M, Sahal D (2013) Evaluation of antiplasmodial activity of green synthesized silver nanoparticles. Colloids Surf B 111:713–718
Moghaddam AB, Moniri M, Azizi S, Rahim RA, Ariff AB, Saad WZ, Namvar F, Navaderi M (2017) Biosynthesis of ZnO nanoparticles by a new Pichia kudriavzevii yeast strain and evaluation of their antimicrobial and antioxidant activities. Molecules 22
Monge-Maillo B, Norman FF, Cruz I, Alvar J, López-Vélez R (2014) Visceral leishmaniasis and HIV coinfection in the mediterranean region. PLoS Neglected Trop Dis 8:3021
Müller IB, Hyde JE, Wrenger C (2010) Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. Trends Parasitol 26:35–43
Murthy S, Keystone J, Kissoon N (2013) Infections of the developing world. Crit Care Clin 29:485–507
Murugan K, Samidoss CM, Panneerselvam C, Higuchi A, Roni M, Suresh U, Chandramohan B, Subramaniam J, Madhiyazhagan P, Dinesh D, Rajaganesh R, Alarfaj AA, Nicoletti M, Kumar S, Wei H, Canale A, Mehlhorn H, Benelli G (2015) Seaweed-synthesized silver nanoparticles: an eco-friendly tool in the fight against Plasmodium falciparum and its vector Anopheles stephensi? Parasitol Res 114:4087–4097
Murugan K, Panneerselvam C, Subramaniam J, Madhiyazhagan P, Hwang JS, Wang L, Dinesh D, Suresh U, Roni M, Higuchi A, Nicoletti M, Benelli G (2016) Eco-friendly drugs from the marine environment: spongeweed-synthesized silver nanoparticles are highly effective on Plasmodium falciparum and its vector Anopheles stephensi, with little non-target effects on predatory copepods. Environ Sci Pollut Res Int 23:16671–16685
Murugan K, Wei J, Alsalhi MS, Nicoletti M, Paulpandi M, Samidoss CM, Dinesh D, Chandramohan B, Paneerselvam C, Subramaniam J, Vadivalagan C, Wei H, Amuthavalli P, Jaganathan A, Devanesan S, Higuchi A, Kumar S, Aziz AT, Nataraj D, Vaseeharan B, Canale A, Benelli G (2017) Magnetic nanoparticles are highly toxic to chloroquine-resistant Plasmodium falciparum, dengue virus (DEN-2), and their mosquito vectors. Parasitol Res 116:495–502
Nadhman A, Nazir S, Khan MI, Ayub A, Muhammad B, Khan M, Shams DF, Yasinzai M (2015) Visible-light-responsive ZnCuO nanoparticles: benign photodynamic killers of infectious protozoans. Int J Nanomed 10:6891–6903
Nadhman A, Khan MI, Nazir S, Khan M, Shahnaz G, Raza A, Shams DF, Yasinzai M (2016) Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation. Int J Nanomed 11:2451–2461
Nair S, Sasidharan A, Divya Rani VV, Menon D, Nair S, Manzoor K, Raina S (2009) Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci—Mater Med 20(Suppl 1):S235–S241
Navarro JA, Sánchez J, Peñafiel-Verdú C, Buendía AJ, Altimira J, Vilafranca M (2010) Histopathological lesions in 15 cats with leishmaniosis. J Comp Pathol 143(4):297–302
Nilforoushzadeh MA, Shirani-Bidabadi LA, Zolfaghari-Baghbaderani A, Jafari R, Heidari-Beni M, Siadat AH, Ghahraman-Tabrizi M (2012) Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice. J Vector Borne Dis 49:249–253
Norman FF, Pérez de Ayala A, Pérez-Molina JA, Monge-Maillo B, Zamarrón P, López-Vélez R (2010) Neglected tropical diseases outside the tropics. PLOS Neglected Trop Dis 4:762
Panneerselvam C, Murugan K, Roni M, Aziz AT, Suresh U, Rajaganesh R, Madhiyazhagan P, Subramaniam J, Dinesh D, Nicoletti M, Higuchi A, Alarfaj AA, Munusamy MA, Kumar S, Desneux N, Benelli G (2016) Fern-synthesized nanoparticles in the fight against malaria: LC/MS analysis of Pteridium aquilinum leaf extract and biosynthesis of silver nanoparticles with high mosquitocidal and antiplasmodial activity. Parasitol Res 115:997–1013
Rahul S, Chandrashekhar P, Hemant B, Bipinchandra S, Mouray E, Grellier P, Satish P (2015) In vitro antiparasitic activity of microbial pigments and their combination with phytosynthesized metal nanoparticles. Parasitol Int 64:353–356
Rai MK, Deshmukh SD, Ingle AP, Gade AK (2012) Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 112:841–852
Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M (2014) Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol 98:1951–1961
Rai M, Deshmukh SD, Ingle AP, Gupta IR, Galdiero M, Galdiero S (2016) Metal nanoparticles: the protective nanoshield against virus infection. Crit Rev Microbiol 42:46–56
Rai M, Ingle AP, Paralikar P, Gupta I, Medici S, Santos CA (2017) Recent advances in use of silver nanoparticles as antimalarial agents. Int J Pharm 526:254–270
Rajakumar G, Rahuman AA, Chung IM, Kirthi AV, Marimuthu S, Anbarasan K (2015) Antiplasmodial activity of eco-friendly synthesized palladium nanoparticles using Eclipta prostrata extract against Plasmodium berghei in Swiss albino mice. Parasitol Res 114:1397–1406
Rathore D, McCutchan TF, Sullivan M, Kumar S (2005) Antimalarial drugs: current status and new developments. Expert Opin Investig Drugs 14:871–883
Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB (2008) Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 61:869–876
Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM (2008) A preliminary assessment of silver nanoparticles inhibition of Monkey poxvirus plaque formation. Nanoscale Res Lett 3:129–133
Salem ANB, Zyed R, Lassoued MA, Nidhal S, Sfar S, Mahjoub A (2012) Plant-derived nanoparticles enhance antiviral activity against Coxsakie virus B3 by acting on virus particles and vero cells. Dig J Nanomater Biostruct 7:737–744
Sazgarnia A, Taheri AR, Soudmand S, Parizi AJ, Rajabi O, Darbandi MS (2013) Antiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major. Int J Hyperth 29:79–86
Sindermann H, Engel J (2006) Development of miltefosine as an oral treatment for leishmaniasis. Trans R Soc Trop Med Hyg 1:17–20
Song X, Zhang J, Li E, Lu N, Yin F (2006) Preparation and characterization of rare-earth bulks with controllable nanostructures. Nanotechnology 17:5584–5589
Speshock JL, Murdock RC, Braydich-Stolle LK, Schrand AM, Hussain SM (2010) Interaction of silver nanoparticles with Tacaribe virus. J Nanobiotechnol 8:19
Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425
Subramaniam J, Murugan K, Panneerselvam C, Kovendan K, Madhiyazhagan P, Dinesh D, Kumar PM, Chandramohan B, Suresh U, Rajaganesh R, Alsalhi MS, Devanesan S, Nicoletti M, Canale A, Benelli G (2016) Multipurpose effectiveness of Couroupita guianensis-synthesized gold nanoparticles: high antiplasmodial potential, field efficacy against malaria vectors and synergy with Aplocheilus lineatus predators. Environ Sci Pollut Res Int 23:7543–7558
Sun L, Singh AK, Vig K, Pillai S, Shreekumar R, Singh SR (2008) Silver nanoparticles inhibit replication of respiratory Sincytial virus. J Biomed Nanotechnol 4:149–158
Sun RW, Chen R, Chung NP, Ho CM, Lin CL, Che CM (2005) Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun 40:5059–5061
Sundar S, Olliaro PL (2007) Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther Clin Risk Manag 3:733–740
Sundar S, Chakravarty J (2015) Investigational drugs for visceral leishmaniasis. Expert Opin Investig Drugs 24:43–59
Suresh U, Murugan K, Benelli G, Nicoletti M, Barnard DR, Panneerselvam C, Kumar PM, Subramaniam J, Dinesh D, Chandramohan B (2015) Tackling the growing threat of dengue: Phyllanthus niruri-mediated synthesis of silver nanoparticles and their mosquitocidal properties against the dengue vector Aedes aegypti (Diptera Culicidae). Parasitol Res 114:1551–1562
Taylor U, Rehbock C, Streich C, Rath D, Barcikowski S (2014) Rational design of gold nanoparticle toxicology assays: a question of exposure scenario, dose and experimental setup. Nanomedicine 9:1971–1989
Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BP, Nakamura CV (2011) Recent advances in leishmaniasis treatment. Int J Infect Dis 15:525–532
Trefry JC, Wooley DP (2013) Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J Biomed Nanotechnol 9:1624–1635
Uchida M, Terashima M, Cunningham CH, Suzuki Y, Willits DA, Willis AF, Yang PC, Tsao PS, McConnell MV, Young MJ, Douglas T (2008) A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med 60:1073–1081
Utzinger J, Keiser J (2004) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5:263–285
Vijayakumar S, Ganesan S (2012) Gold nanoparticles as an HIV entry inhibitor. Curr HIV Res 10:643–646
Wang H, Li Q, Reyes S, Zhang J, Zeng Q, Zhang P, Xie L, Lee PJ, Roncal N, Melendez V, Hickman M, Kozar MP (2014) Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice. Nanomedicine 10:57–65
World Health Organization, WHO (2010) Control of the leishmaniasis. World Health Organ Tech Rep 949:22–26
World Health Organization, WHO (2013) Sustaining the drive to overcome the global impact of neglected tropical diseases. Second WHO report on neglected tropical diseases
World Health Organization, WHO (2015) http://www.who.int/mediacentre/news/releases/2016/malaria-control-africa/en/
World Health Organization, WHO (2017) http://www.who.int/mediacentre/factsheets/fs259/en/
Wrenger C, Eschbach ML, Müller IB, Warnecke D, Walter RD (2005) Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum. J Biol Chem 280:5242–5248
Wrenger C, Eschbach ML, Müller IB, Laun NP, Begley TP, Walter RD (2006) Vitamin B1 de novo synthesis in the human malaria parasite Plasmodium falciparum depends on external provision of 4-amino-5-hydroxymethyl-2-methylpyrimidine. Biol Chem 387:41–51
Xiang DX, Chen Q, Pang L, Zheng CL (2011) Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods 178:137–142
Yao J, van Marwijk J, Wilhelmi B, Whiteley CG (2015) Isolation, characterization, interaction of a thiazolekinase (Plasmodium falciparum) with silvernanoparticles. Int J Biol Macromol 79:644–653
Zahir AA, Chauhan IS, Bagavan A, Kamaraj C, Elango G, Shankar J, Arjaria N, Roopan SM, Rahuman AA, Singh N (2015) Green synthesis of silver and titanium dioxide nanoparticles using Euphorbia prostrata extract shows shift from apoptosis to G0/G1 arrest followed by necrotic cell death in Leishmania donovani. Antimicrob Agents Chemother 59:4782–4799
Zhang X, Li W, Yang Z (2015a) Toxicology of nanosized titanium dioxide: an update. Arch Toxicol 89:2207–2217
Zhang Y, Shareena Dasari TP, Deng H, Yu H (2015b) Antimicrobial activity of gold nanoparticles and ionic gold. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 33:286–327
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Della Pepa, M.E., Martora, F., Finamore, E., Vitiello, M., Galdiero, M., Franci, G. (2017). Role of Nanoparticles in Treatment of Human Parasites. In: Rai, M., Alves dos Santos, C. (eds) Nanotechnology Applied To Pharmaceutical Technology. Springer, Cham. https://doi.org/10.1007/978-3-319-70299-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-70299-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70298-8
Online ISBN: 978-3-319-70299-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)